On Wednesday 30th October 2024, Teladoc Health (NYSE: TDOC) will be releasing its third quarter financial results. This much awaited announcement will be made after market close.
As per the predictions of financial analysts on Wall Street, the firm is set to report an estimated per share $0.27 loss for the third quarter. Additionally, the company is projected to unveil a revenue of $631.16 million for the period.
In comparison to the same quarter of the prior year, the company's financial statement showcased a per share of loss of $0.35. This was credited to the company's total revenue, which reached an impressive $660.24 million in that particular timeframe.
Wall Street analysts have revealed their projections for the company's yearly performance, with a total revenue of $2.55 billion. Furthermore, they expect the business to achieve loss of $5.59 per share during the fiscal year.
In addition, The firm will review the third quarter financial results on 30th October 2024 at 04:30 PM eastern time, in a conference call with public.
Teladoc Health (TDOC) shares traded as low as $8.65 and as high as $9.35 on a day volume of 4.85 million shares, closed Monday's regular trading session at $9.18, a gain of 7.12 percent.
